- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Charles River Laboratories International Inc
+ Add to WatchlistRV6:GR
33.784 EUR 0.531 1.55%As of 03:03:07 ET on 05/23/2013.
Snapshot for Charles River Laboratories International Inc (RV6)
| Open: | 33.780 | Day's Range: | 33.780 - 34.110 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 34.315 | 52wk Range: | 23.950 - 35.560 | 1-Yr Rtn: | +29.42% |
Key Statistics for RV6
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 15.5036 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 2.8080 |
| Est. PEG Ratio | 1.6088 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 11 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/07/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for RV6
Company Profile & Key Executives for RV6
Charles River Laboratories International, Inc. provides research tools and support services that enable drug discovery and development. The Company pro- vides the animal research models required in research and development for new drugs, devices, and therapies. Charles River's customers include pharmaceutical and biotechnology companies, hospitals, and academic institutions.
| James C FosterChairman/President/CEO | Thomas F AckermanExec VP/CFO |
| Nancy A GillettExec VP/Chief Scientific Ofcr | David P JohstExec VP:HR/CAO/Secy/Gen Cnsl |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
RV6 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page